Skip to main content
Veterinary Medicines

ZIPYRAN TABLETS FOR DOGS

Authorised
This information is not available for this product.

Product identification

Medicine name:
ZIPYRAN TABLETS FOR DOGS
Zipyran таблетки за кучета
Active substance:
This information is not available for this product.
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:
  • Cardboard box containing 1 blister of 2 tablets
  • Cardboard box containing 2 blisters of 2 tablets
  • Cardboard box containing 1 blister of 4 tablets
  • Cardboard box containing 3 blisters of 2 tablets
  • Cardboard box containing 4 blisters of 2 tablets
  • Cardboard box containing 1 blister of 10 tablets
  • Cardboard box containing 25 blisters of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
  • Beaphar B.V.
  • Beaphar B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2634
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0224/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Germany
  • Greece
  • Italy
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 22/03/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."